Boris Brus
Impact in
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
-
- Computational Drug Discovery Methods
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 9
-
- Computational Drug Discovery Methods 5
- Co-authors
- Stanislav Gobec (21 shared papers)Anja Hafner Pišlar (5 shared papers)Janko Kos (5 shared papers)Jacques‐Philippe Colletier (4 shared papers)Nicolas Coquelle (4 shared papers)Urban Košak (4 shared papers)Jure Stojan (4 shared papers)Damijan Knez (6 shared papers)
In The Last Decade
Boris Brus
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Pharmacology 643
- Computational Theory and Mathematics 128
- Organic Chemistry 146
- Physiology 100
- Molecular Biology 154
Countries citing papers authored by Boris Brus
This map shows the geographic impact of Boris Brus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Brus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Brus more than expected).
Fields of papers citing papers by Boris Brus
This network shows the impact of papers produced by Boris Brus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Brus. The network helps show where Boris Brus may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Brus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 260 | |
| 2 | 2016 | 150 | |
| 3 | 2017 | 148 | |
| 4 | 2015 | 69 | |
| 5 | 2015 | 64 | |
| 6 | 2016 | 62 | |
| 7 | 2015 | 58 | |
| 8 | 2015 | 48 | |
| 9 | 2016 | 46 | |
| 10 | 2015 | 44 | |
| 11 | 2018 | 44 | |
| 12 | 2013 | 40 | |
| 13 | 2019 | 26 | |
| 14 | 2017 | 24 | |
| 15 | 2021 | 22 | |
| 16 | 2012 | 16 | |
| 17 | 2017 | 15 | |
| 18 | 2011 | 14 | |
| 19 | 2014 | 13 | |
| 20 | 2015 | 12 |
About Boris Brus
Boris Brus is a scholar working on Pharmacology, Computational Theory and Mathematics, Cancer Research, Cell Biology and Molecular Biology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (9 papers), Computational Drug Discovery Methods (5 papers), Protease and Inhibitor Mechanisms (2 papers), Aldose Reductase and Taurine (2 papers), Ubiquitin and proteasome pathways (2 papers), Protein purification and stability (2 papers), Biochemical and Structural Characterization (1 paper) and Plant-Microbe Interactions and Immunity (1 paper). The work is most often cited by research in Pharmacology (643 citations), Computational Theory and Mathematics (128 citations), Organic Chemistry (146 citations), Physiology (100 citations) and Molecular Biology (154 citations). Boris Brus has collaborated with scholars based in Slovenia, France and Poland. Frequent co-authors include Stanislav Gobec, Anja Hafner Pišlar, Janko Kos, Jacques‐Philippe Colletier, Nicolas Coquelle, Urban Košak, Jure Stojan, Damijan Knez, Xavier Brazzolotto and Barbara Malawska. Their work appears in journals such as Bioorganic & Medicinal Chemistry, The Journal of Steroid Biochemistry and Molecular Biology, Journal of Chemical Information and Modeling, Scientific Reports and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.